149 related articles for article (PubMed ID: 1664901)
1. A multivariate study of the relationship between regional lymph node metastases and prognosis in patients with operable breast cancer.
Noguchi M; Taniya T; Koyasaki N; Ohta N; Miyazaki I
Jpn J Surg; 1991 Nov; 21(6):613-20. PubMed ID: 1664901
[TBL] [Abstract][Full Text] [Related]
2. Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer.
Noguchi M; Ohta N; Koyasaki N; Taniya T; Miyazaki I; Mizukami Y
Cancer; 1991 Nov; 68(9):1918-25. PubMed ID: 1655229
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic significance of internal mammary lymph node metastases in breast cancer patients].
Noguchi M; Ota N; Koyazaki N; Taniya T; Miyazaki I; Mizukami Y
Nihon Geka Gakkai Zasshi; 1992 Mar; 93(3):295-9. PubMed ID: 1513310
[TBL] [Abstract][Full Text] [Related]
4. Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes.
Veronesi U; Cascinelli N; Greco M; Bufalino R; Morabito A; Galluzzo D; Conti R; De Lellis R; Delle Donne V; Piotti P
Ann Surg; 1985 Dec; 202(6):702-7. PubMed ID: 3000303
[TBL] [Abstract][Full Text] [Related]
5. C-erbB-2 oncoprotein expression versus internal mammary lymph node metastases as additional prognostic factors in patients with axillary lymph node-positive breast cancer.
Noguchi M; Koyasaki N; Ohta N; Kitagawa H; Earashi M; Thomas M; Miyazaki I; Mizukami Y
Cancer; 1992 Jun; 69(12):2953-60. PubMed ID: 1350504
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of lymph-node level involvement in patients undergoing axillary dissection for breast cancer.
Canavese G; Catturich A; Vecchio C; Tomei D; Gipponi M; Bruzzi P; Badellino F
Eur J Surg Oncol; 1998 Apr; 24(2):104-9. PubMed ID: 9591024
[TBL] [Abstract][Full Text] [Related]
7. Risk of internal mammary lymph node metastases and its prognostic value in breast cancer patients.
Noguchi M; Ohta N; Thomas M; Kitagawa H; Miyazaki I
J Surg Oncol; 1993 Jan; 52(1):26-30. PubMed ID: 8441257
[TBL] [Abstract][Full Text] [Related]
8. The relationship between lymph node metastases and DNA-ploidy status as prognostic factors in invasive breast cancer.
Noguchi M; Ohta N; Koyasaki N; Taniya T; Miyazaki I; Mizukami Y
Surg Today; 1992; 22(3):213-20. PubMed ID: 1392324
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
10. Complete axillary lymph node dissection for stage I-II carcinoma of the breast.
Danforth DN; Findlay PA; McDonald HD; Lippman ME; Reichert CM; d'Angelo T; Gorrell CR; Gerber NL; Lichter AS; Rosenberg SA
J Clin Oncol; 1986 May; 4(5):655-62. PubMed ID: 3701387
[TBL] [Abstract][Full Text] [Related]
11. [A new perspective on axillary dissection in situations of metastatic sentinel node].
Zedníková I; Ňaršanská A; Hes O; Metelková A; Fiala O; Svoboda T
Rozhl Chir; 2017; 96(8):346-352. PubMed ID: 29058925
[TBL] [Abstract][Full Text] [Related]
12. Risk of internal mammary lymph node metastases and its relevance on prognosis of breast cancer patients.
Veronesi U; Cascinelli N; Bufalino R; Morabito A; Greco M; Galluzzo D; Delle Donne V; De Lellis R; Piotti P; Sacchini V
Ann Surg; 1983 Dec; 198(6):681-4. PubMed ID: 6639172
[TBL] [Abstract][Full Text] [Related]
13. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.
Diel IJ; Kaufmann M; Costa SD; Holle R; von Minckwitz G; Solomayer EF; Kaul S; Bastert G
J Natl Cancer Inst; 1996 Nov; 88(22):1652-8. PubMed ID: 8931609
[TBL] [Abstract][Full Text] [Related]
14. Gamma-probe-guided resection of the sentinel lymph node in breast cancer.
Crossin JA; Johnson AC; Stewart PB; Turner WW
Am Surg; 1998 Jul; 64(7):666-8; discussion 669. PubMed ID: 9655279
[TBL] [Abstract][Full Text] [Related]
15. Internal mammary nodal status is a more reliable prognostic factor than DNA ploidy and c-erb B-2 expression in patients with breast cancer.
Noguchi M; Koyasaki N; Ohta N; Kitagawa H; Earashi M; Thomas M; Miyazaki I; Mizukami Y
Arch Surg; 1993 Feb; 128(2):242-6. PubMed ID: 8094282
[TBL] [Abstract][Full Text] [Related]
16. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.
Veronesi U; Paganelli G; Galimberti V; Viale G; Zurrida S; Bedoni M; Costa A; de Cicco C; Geraghty JG; Luini A; Sacchini V; Veronesi P
Lancet; 1997 Jun; 349(9069):1864-7. PubMed ID: 9217757
[TBL] [Abstract][Full Text] [Related]
17. Pilot study comparing the accuracy of lymphoscintigraphy sentinel lymph node localisation with axillary node dissection in women with operable breast cancer.
Allen B; Campbell I; Desai S; Dray M; Scarlet J
N Z Med J; 2001 May; 114(1132):233-6. PubMed ID: 11453361
[TBL] [Abstract][Full Text] [Related]
18. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases.
Nos C; Harding-MacKean C; Fréneaux P; Trie A; Falcou MC; Sastre-Garau X; Clough KB
Br J Surg; 2003 Nov; 90(11):1354-60. PubMed ID: 14598414
[TBL] [Abstract][Full Text] [Related]
19. Intra-mammary tumor location does not influence prognosis but influences the prevalence of axillary lymph-node metastases.
Janni W; Rack B; Sommer H; Schmidt M; Strobl B; Rjosk D; Klanner E; Thieleke W; Gerber B; Friese K; Dimpfl T
J Cancer Res Clin Oncol; 2003 Sep; 129(9):503-10. PubMed ID: 12884027
[TBL] [Abstract][Full Text] [Related]
20. Initial experience with sentinel node biopsy in breast cancer at the National Cancer Center Hospital East.
Imoto S; Hasebe T
Jpn J Clin Oncol; 1999 Jan; 29(1):11-5. PubMed ID: 10073145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
